BACKGROUND: MicroRNAs (miRNAs) regulate expression of many cancer-related genes through posttranscriptional repression of their mRNAs. In this study we investigate the proto-oncogene MYCN as a target for miRNA regulation. METHODS: A luciferase reporter assay was used to investigate software-predicted miRNA target sites in the 30 -untranslated region (30 UTR) of MYCN. The miRNAs were overexpressed in cell lines by transfection of miRNA mimics or miRNA-expressing plasmids. Mutation of the target sites was used to validate MYCN 30 UTR as a direct target of several miRNAs. To measure miRNA-mediated suppression of endogenous N-myc protein, inhibition of proliferation and inhibition of clonogenic growth, miRNAs were overexpressed in a MYCN-amplif...
Increased activity of MYC protein-family members is a common feature in many cancers. Using neurobla...
MYCN, an oncogenic transcription factor of the Myc family, is a major driver of neuroblastoma tumori...
Neuroblastoma is a pediatric cancer whose heterogeneous nature is reflected in clinically favorable ...
BACKGROUND: MicroRNAs (miRNAs) regulate expression of many cancer-related genes through posttranscri...
MYCN is a transcription factor that plays key roles in both normal development and cancer. In neurob...
MYCN is a transcription factor that plays key roles in both normal development and cancer. In neurob...
MYCN plays a central role in neuroblastoma development and exerts a pleiotropic role through the reg...
MYCN plays a central role in neuroblastoma development and exerts a pleiotropic role through the reg...
MYCN is a transcription factor that plays key roles in both normal development and cancer. In neurob...
Neuroblastoma is a childhood cancer derived from embryonic neural crest cells of the peripheral symp...
MicroRNAs (miRNAs) are 22-24 nucleotides non-coding RNAs that can simultaneously influence the level...
MicroRNAs are small molecules which regulate gene expression post-transcriptionally and aberrant exp...
© 2018 American Association for Cancer Research. Neuroblastoma is a pediatric cancer of the sympathe...
AbstractmicroRNAs (miRNAs) are a new class of non-protein-coding, endogenous, small RNAs. They are i...
Neuroblastoma is the most common extracranial solid tumor in children. Both cellular heterogeneity a...
Increased activity of MYC protein-family members is a common feature in many cancers. Using neurobla...
MYCN, an oncogenic transcription factor of the Myc family, is a major driver of neuroblastoma tumori...
Neuroblastoma is a pediatric cancer whose heterogeneous nature is reflected in clinically favorable ...
BACKGROUND: MicroRNAs (miRNAs) regulate expression of many cancer-related genes through posttranscri...
MYCN is a transcription factor that plays key roles in both normal development and cancer. In neurob...
MYCN is a transcription factor that plays key roles in both normal development and cancer. In neurob...
MYCN plays a central role in neuroblastoma development and exerts a pleiotropic role through the reg...
MYCN plays a central role in neuroblastoma development and exerts a pleiotropic role through the reg...
MYCN is a transcription factor that plays key roles in both normal development and cancer. In neurob...
Neuroblastoma is a childhood cancer derived from embryonic neural crest cells of the peripheral symp...
MicroRNAs (miRNAs) are 22-24 nucleotides non-coding RNAs that can simultaneously influence the level...
MicroRNAs are small molecules which regulate gene expression post-transcriptionally and aberrant exp...
© 2018 American Association for Cancer Research. Neuroblastoma is a pediatric cancer of the sympathe...
AbstractmicroRNAs (miRNAs) are a new class of non-protein-coding, endogenous, small RNAs. They are i...
Neuroblastoma is the most common extracranial solid tumor in children. Both cellular heterogeneity a...
Increased activity of MYC protein-family members is a common feature in many cancers. Using neurobla...
MYCN, an oncogenic transcription factor of the Myc family, is a major driver of neuroblastoma tumori...
Neuroblastoma is a pediatric cancer whose heterogeneous nature is reflected in clinically favorable ...